Teresia Osborn

Teresia Osborn serves as the Associate Scientific Director in the ALS Discovery Group at Biogen since April 2022. With a robust career spanning over two decades, Teresia holds a dual position as Assistant Neuroscientist at McLean Hospital, where responsibilities include directing in vitro research programs, serving as principal investigator, and acting as laboratory safety officer. Previous experience includes consulting for Oryon Cell Therapies Inc., leading research at the Neuroregeneration Research Institute, and instructing at Harvard Medical School. Teresia's academic background includes a Ph.D. in Medicine/Cell Biology and an M.S. in Pharmaceutical Bioscience from the University of Gothenburg, Sweden.